|30th October 2020||Jack W Schuler||245,041||Conversion of derivative||$0.00|
|30th October 2020||Jack W Schuler||277,777||Open or private purchase||$18.00||$4,999,986.00|
|30th October 2020||Jack W Schuler||753,735||Conversion of derivative||$14.40||$10,853,784.00|
|30th October 2020||Jack W Schuler||4,668,046||Conversion of derivative||$0.00|
|26th August 2020||Jack W Schuler||365,241||Open or private purchase||$4.25||$1,552,274.25|
|11th August 2020||Kristi Snell||587||Payment by withholding||$6.55||$3,844.85|
|11th August 2020||Lynne H Brum||587||Payment by withholding||$6.55||$3,844.85|
|11th August 2020||Charles B Haaser||587||Payment by withholding||$6.55||$3,844.85|
|11th August 2020||Oliver P Peoples||733||Payment by withholding||$6.55||$4,801.15|
|1st July 2020||Jack W Schuler||2,285,715||Open or private purchase||$3.50||$8,000,002.50|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Yield10 Bioscience, Inc. focuses on the development of technologies to produce step-change improvements in crop yield. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992.